News: Vernalis PLC (VER.L)

VER.L on London Stock Exchange

90.00GBp
18 Dec 2009
Price Change (% chg)

-0.50p (-0.55%)
Prev Close
90.50p
Open
90.00p
Day's High
90.00p
Day's Low
90.00p
Volume
2,356
Avg. Vol
6,721
52-wk High
111.00p
52-wk Low
39.40p

view news for:
Select another date:

Thu, Aug 6 2009

UPDATE 1-Glaxo, Vernalis sign up to $200 mln cancer deal

* Vernalis gets $6 mln upfront, up to $200 mln in milestones

Continue Reading

Vernalis CEO says M&A takes about half his time

LONDON (Reuters) - British biotech company Vernalis said on Tuesday about half its management time is taken up by efforts to secure an acquisition, suggesting a deal first promised last November may be getting closer.

UK Stocks -- Factors to watch on June 25

LONDON, June 25 (Reuters) - Britain's FTSE 100 index is seen opening 3-15 points lower on Thursday, according to financial bookmakers, retreating following a mixed performance on Wall Street after Federal Reserve comments failed to excite.

STOCKS NEWS EUROPE-Vernalis soars after Korea update

Shares in British biotechnology company Vernalis soar 13 percent after the company announces that its Korean partner SK Chemicals has gained approval to market its frovatriptan drug in South Korea.

STOCKS NEWS UK SMALL-Vernalis soars after Korea update

STOCKS NEWS Reuters Results diary

Consolidation may immunise biotech investors

LONDON (Reuters) - After seeing the value of investments tumble in the credit crisis, an emerging trend of industry consolidation in the UK biotech sector could be a welcome shot in the arm for investors.

Consolidation may immunise biotech investors

LONDON (Reuters) - After seeing the value of investments tumble in the credit crisis, an emerging trend of industry consolidation in the UK biotech sector could be a welcome shot in the arm for investors.

Biotech firm Vernalis' new CEO pledges change

LONDON (Reuters) - Vernalis on Friday appointed the former management team from Acambis to head the British biotechnology company, and the group's incoming Chief Executive promised significant changes.

UK biotech firm Vernalis' new CEO pledges change

* Incoming CEO says company "will not be what it is today"

STOCKS NEWS UK SMALL-Asterand up on bullish trading statement

STOCKS NEWS Reuters Results diary

Select another date:

Market Views

» More VER.L Market Views

Press Releases

view news for: